Efficacy and Safety of Odanacatib (MK-0822) in Participants With Involutional Osteoporosis (MK-0822-022)

Clinical trial NCT00620113 · COMPLETED

Trial details

NCT number: NCT00620113
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Osteoporosis Postmenopausal

Start date: 2007-12-03
Primary completion: 2009-05-29
Enrollment: 287

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.